Page 3 - Pipeline Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pipeline updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pipeline Updates Today - Breaking & Trending Today

Eisai Presents New Data on the Relationship Between Clinical, Biomarker and Safety Outcomes from the Lecanemab Phase 2B Study

For Early Alzheimer's Disease in Late-Breakers and Pipeline Updates at the 14th Clinical Trials on Alzheimer's Disease (CTAD) ConferenceTOKYO, Nov 4, 2021 - (JCN Newswire) - Eisai Co., Ltd. announced today ....

United States , Ivan Cheung , Michael Irizarry , Eisai Co Ltd , Neurology Business Group , Eisai Inc , Drug Administration , Early Alzheimer , Pipeline Updates , Clinical Trials , Biologics License Application , Vice President , Deputy Chief Clinical Officer , Senior Vice President , President Neurology Business Group , Global Alzheimer , Disease Officer ,

Investegate |Syncona Limited Announcements | Syncona Limited: Autolus reports Q3 2021 Financial Results

Investegate announcements from Syncona Limited, Autolus reports Q3 2021 Financial Results ....

United States , United Kingdom , City Of , Sumitomo Dainippon Pharma , Edgar Braendle , Annabel Clay Fergus Witt , Eli Lilly , Johnh Johnson , Julia Wilson , Chris Williams , Strongbridge Biopharma , Wolfram Brugger , Matthias Alder , Collins Tim Stamper , Lucinda Crabtree , Alexander Swan , Susana Noonan , Sumitomo Dainippon , Ben Atwell Natalie , Development Officer , Exchange Commission On , European Hematology Association , Reef Group , Axogen Inc , Moderna Inc , Virtual Congress ,

Investegate |Silence Therapeutics Announcements | Silence Therapeutics: Silence Provides Pipeline Updates at 2021 R&D Day

Investegate announcements from Silence Therapeutics, Silence Provides Pipeline Updates at 2021 R&D Day ....

New York , United States , City Of , United Kingdom , Giles Campion , Mark Rothera , Mary Conway , Daniel Adams Gary Clarence , Mallinckrodt Pharmaceuticals , Exchange Commission On , Investec Bank , Company Rd Day , American Society Of Hematology , Corporate Communications , Program Updates , Consilium Strategic Communications , Silence Therapeutics Provides , Pipeline Updates , New York City , Chief Executive Officer , Silence Therapeutics , Chief Medical Officer , Proprietary Program , American Society , Annual Meeting , Partnered Program ,

Autolus Therapeutics Reports First Quarter 2021 Financial Results and Operational Progress- Conference call to be held on May 6, 2021 at 8:30 am ET/1:30 pm BST -

Published: May 06, 2021
LONDON, May 06, 2021 (GLOBE NEWSWIRE) Autolus plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced its operational and financial results for the quarter ended March 31, 2021.
“We have had a productive first quarter and are on track for multiple clinical read outs during the remainder of this year and into 2022,” said Dr. Christian Itin, chief executive officer of Autolus. “We are excited by the unique characteristics of AUTO1 and encouraged by what we believe is the significant clinical benefit AUTO1 can offer for patients with relapsed/refractory (r/r) Acute Lymphoblastic Leukemia (ALL). AUTO1 is being evaluated in the P1b/2 FELIX study in adult ALL patients with data expected in 2022. In addition, AUTO1 is being explored in patients with B-NHL and in primary CNS lymphoma, and we are also evaluating AUTO1/22 in pediatric ALL patients. Finally, several p ....

City Of , United Kingdom , United States , Susana Noonan , Julia Wilson , Martin Murphy , Muhammad Al , Exchange Commission On , European Hematology Association , Sa Noonan Communications , International Nonproprietary Name , Translational Sciences , Regulatory Agency , Exchange Commission , European Medicines Agency , Christian Itin , Acute Lymphoblastic Leukemia , Pipeline Updates , B Acute Lymphocytic Leukemia , Non Hodgkin Lymphoma , Peripheralt Cell Lymphoma , United Kingdom Medicines , Coronavirus Disease , Open Market Sales , Gene Therapy Catapult , Muhammad Al Hajj ,

Investegate |Syncona Limited Announcements | Syncona Limited: Autolus reports Q1 2021 Financial Results

06 May 2021
Syncona Ltd, a leading healthcare company focused on founding, building and funding a portfolio of global leaders in life science, notes that its portfolio company, Autolus Therapeutics Plc (NASDAQ: AUTL) (Autolus), announced its operational and financial results for the first quarter ended March 31, 2021.
The announcement can be accessed on Autolus investor website at
https://www.autolus.com/investor-relations
and full text of the announcement from Autolus is contained below. Autolus management will host a conference call today, at 8:30 a.m. EDT/ 1:30pm GMT to discuss the company s financial results and operational update. To listen to the webcast and view the accompanying slide presentation, please go to: ....

City Of , United Kingdom , United States , Susana Noonan , Julia Wilson , Collins Tim Stamper , Martin Murphy , Annabel Clay , Muhammad Al , Ben Atwell Natalie , Exchange Commission On , European Hematology Association , Sa Noonan Communications , International Nonproprietary Name , Translational Sciences , Regulatory Agency , Exchange Commission , Autolus Therapeutics Plc , European Medicines Agency , Syncona Ltd , Syncona Limited , Natalie Garland Collins , Therapeutics Reports First Quarter , Autolus Therapeutics , Christian Itin , Acute Lymphoblastic Leukemia ,